Robert J Mitkus

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, 1401 Rockville Pike, HFM 210, Rockville, MD 20852, USA
    Vaccine 31:2738-43. 2013
  2. doi request reprint Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, 1401 Rockville Pike, HFM 210, Rockville, MD 20852, United States
    Vaccine 29:9538-43. 2011
  3. ncbi request reprint A comparative pharmacokinetic estimate of mercury in u.s. Infants following yearly exposures to inactivated influenza vaccines containing thimerosal
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, Rockville, MD, USA
    Risk Anal 34:735-50. 2014

Detail Information

Publications3

  1. doi request reprint Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, 1401 Rockville Pike, HFM 210, Rockville, MD 20852, USA
    Vaccine 31:2738-43. 2013
    ..1 mM, we conclude that residual, exogenously applied formaldehyde continues to be safe following incidental exposures from infant vaccines...
  2. doi request reprint Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, 1401 Rockville Pike, HFM 210, Rockville, MD 20852, United States
    Vaccine 29:9538-43. 2011
    ..We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns...
  3. ncbi request reprint A comparative pharmacokinetic estimate of mercury in u.s. Infants following yearly exposures to inactivated influenza vaccines containing thimerosal
    Robert J Mitkus
    Office of Biostatistics and Epidemiology, USFDA Center for Biologics Evaluation and Research, Rockville, MD, USA
    Risk Anal 34:735-50. 2014
    ..Our pharmacokinetic analysis supports the acknowledged safety of thimerosal when used as a preservative at current levels in certain multidose infant vaccines in the United States. ..